PL2139479T3 - 4-[2-(4-Metylofenylosulfanylo)fenylo]piperydyna o połączonym hamowaniu wychwytu zwrotnego serotoniny i norepinefryny do leczenia ADHD, melancholii, depresji opornej na leczenie lub pozostałych objawów depresji - Google Patents

4-[2-(4-Metylofenylosulfanylo)fenylo]piperydyna o połączonym hamowaniu wychwytu zwrotnego serotoniny i norepinefryny do leczenia ADHD, melancholii, depresji opornej na leczenie lub pozostałych objawów depresji

Info

Publication number
PL2139479T3
PL2139479T3 PL08715618T PL08715618T PL2139479T3 PL 2139479 T3 PL2139479 T3 PL 2139479T3 PL 08715618 T PL08715618 T PL 08715618T PL 08715618 T PL08715618 T PL 08715618T PL 2139479 T3 PL2139479 T3 PL 2139479T3
Authority
PL
Poland
Prior art keywords
depression
treatment
methylphenylsulfanyl
melancholia
adhd
Prior art date
Application number
PL08715618T
Other languages
English (en)
Inventor
Tine Bryan Stensbøl
Silke Miller
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2007/050076 external-priority patent/WO2007144006A1/en
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of PL2139479T3 publication Critical patent/PL2139479T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PL08715618T 2007-03-20 2008-03-14 4-[2-(4-Metylofenylosulfanylo)fenylo]piperydyna o połączonym hamowaniu wychwytu zwrotnego serotoniny i norepinefryny do leczenia ADHD, melancholii, depresji opornej na leczenie lub pozostałych objawów depresji PL2139479T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200700423 2007-03-20
PCT/DK2007/050076 WO2007144006A1 (en) 2006-06-16 2007-06-15 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
EP08715618A EP2139479B1 (en) 2007-03-20 2008-03-14 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
PCT/DK2008/050064 WO2008113360A2 (en) 2007-03-20 2008-03-14 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression

Publications (1)

Publication Number Publication Date
PL2139479T3 true PL2139479T3 (pl) 2013-05-31

Family

ID=39575680

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08715618T PL2139479T3 (pl) 2007-03-20 2008-03-14 4-[2-(4-Metylofenylosulfanylo)fenylo]piperydyna o połączonym hamowaniu wychwytu zwrotnego serotoniny i norepinefryny do leczenia ADHD, melancholii, depresji opornej na leczenie lub pozostałych objawów depresji
PL08758225T PL2167085T3 (pl) 2007-03-20 2008-06-13 4-[2-(4-metylofenylosulfanylo)fenylo]piperydyna do leczenia zespołu nadwrażliwości jelita grubego (ibs)

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL08758225T PL2167085T3 (pl) 2007-03-20 2008-06-13 4-[2-(4-metylofenylosulfanylo)fenylo]piperydyna do leczenia zespołu nadwrażliwości jelita grubego (ibs)

Country Status (27)

Country Link
US (2) US20100144788A1 (pl)
EP (2) EP2139479B1 (pl)
JP (1) JP5388867B2 (pl)
KR (1) KR20090125775A (pl)
CN (2) CN101674830B (pl)
AR (1) AR065798A1 (pl)
AU (1) AU2008228639B2 (pl)
BR (1) BRPI0808831A2 (pl)
CA (1) CA2684556C (pl)
CL (1) CL2008000796A1 (pl)
CO (1) CO6220957A2 (pl)
CY (2) CY1113965T1 (pl)
DK (2) DK2139479T3 (pl)
EA (1) EA017407B1 (pl)
ES (2) ES2399305T3 (pl)
HR (1) HRP20130049T1 (pl)
IL (1) IL200954A (pl)
MX (1) MX2009009934A (pl)
MY (1) MY163537A (pl)
NZ (1) NZ579723A (pl)
PL (2) PL2139479T3 (pl)
PT (2) PT2139479E (pl)
RS (2) RS52676B (pl)
SI (1) SI2139479T1 (pl)
TW (1) TWI432194B (pl)
UA (2) UA97660C2 (pl)
WO (1) WO2008113360A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20110412T1 (hr) * 2006-06-16 2011-06-30 H. Lundbeck A/S Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombiniranom inhibicijom reapsorpcije serotonina i norepinefrina za liječenje neuropatskih bolova
WO2008151632A1 (en) * 2007-06-15 2008-12-18 H.Lundbeck A/S 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine for the treatment of irritable bowel syndrome (ibs)
TWI432194B (zh) 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
TW200938194A (en) * 2007-12-14 2009-09-16 Lundbeck & Co As H Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter
EP2564837B1 (en) * 2010-04-30 2019-01-30 Takeda Pharmaceutical Company Limited Enteric tablet
US8745134B1 (en) 2011-03-04 2014-06-03 Zynga Inc. Cross social network data aggregation
US8332488B1 (en) 2011-03-04 2012-12-11 Zynga Inc. Multi-level cache with synch
US8347322B1 (en) 2011-03-31 2013-01-01 Zynga Inc. Social network application programming interface
US10135776B1 (en) 2011-03-31 2018-11-20 Zynga Inc. Cross platform social networking messaging system
US8522137B1 (en) 2011-06-30 2013-08-27 Zynga Inc. Systems, methods, and machine readable media for social network application development using a custom markup language
WO2018002115A1 (en) 2016-07-01 2018-01-04 H. Lundbeck A/S Vortioxetine dosing regimes for fast onset of antidepressant effect
WO2020087031A1 (en) 2018-10-26 2020-04-30 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004539B1 (ru) * 1998-05-22 2004-06-24 Эли Лилли Энд Компани Комбинационная терапия для лечения резистентной депрессии
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
SI1626720T1 (sl) * 2003-04-04 2008-12-31 Lundbeck & Co As H Derivati 4-(2-fenilsulfanil-fenil)-piperidina kotzaviralci ponovnega vnosa serotonina
JP2006522027A (ja) * 2003-04-04 2006-09-28 ハー・ルンドベック・アクチエゼルスカベット セロトニン再取り込み阻害剤としての４−（２−フェニルオキシフェニル）−ピペリジンまたは−１，２，３，６−テトラヒドロピリジン誘導体
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
DE102006028034A1 (de) * 2006-06-14 2007-12-20 Leifheit Ag Bürste und Kehrgerät mit Bürste
HRP20110412T1 (hr) * 2006-06-16 2011-06-30 H. Lundbeck A/S Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombiniranom inhibicijom reapsorpcije serotonina i norepinefrina za liječenje neuropatskih bolova
TWI405588B (zh) 2007-03-20 2013-08-21 Lundbeck & Co As H ４-〔２-（４-甲苯基硫基）-苯基〕哌啶之鹽類的液體調配物
TWI432194B (zh) 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
TW200938194A (en) * 2007-12-14 2009-09-16 Lundbeck & Co As H Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter

Also Published As

Publication number Publication date
CN101674830B (zh) 2012-05-09
CO6220957A2 (es) 2010-11-19
CN101674830A (zh) 2010-03-17
AU2008228639B2 (en) 2012-12-13
CN101646438B (zh) 2012-04-11
HK1142007A1 (en) 2010-11-26
MY163537A (en) 2017-09-15
EA200970871A1 (ru) 2010-04-30
HRP20130049T1 (hr) 2013-02-28
PT2139479E (pt) 2013-02-20
UA99611C2 (ru) 2012-09-10
RS53138B (sr) 2014-06-30
CY1114774T1 (el) 2016-12-14
SI2139479T1 (sl) 2013-04-30
WO2008113360A3 (en) 2008-11-13
EP2167085A1 (en) 2010-03-31
IL200954A0 (en) 2010-05-17
CY1113965T1 (el) 2016-07-27
CA2684556C (en) 2013-01-08
BRPI0808831A2 (pt) 2014-08-26
TW200848032A (en) 2008-12-16
EP2139479A2 (en) 2010-01-06
AU2008228639A1 (en) 2008-09-25
CA2684556A1 (en) 2008-09-25
US20100137366A1 (en) 2010-06-03
EA017407B1 (ru) 2012-12-28
TWI432194B (zh) 2014-04-01
UA97660C2 (ru) 2012-03-12
WO2008113360A2 (en) 2008-09-25
DK2139479T3 (da) 2013-02-11
MX2009009934A (es) 2009-09-24
PL2167085T3 (pl) 2014-08-29
DK2167085T3 (da) 2014-02-03
CL2008000796A1 (es) 2008-09-26
NZ579723A (en) 2011-07-29
AR065798A1 (es) 2009-07-01
CN101646438A (zh) 2010-02-10
KR20090125775A (ko) 2009-12-07
PT2167085E (pt) 2014-02-17
US20100144788A1 (en) 2010-06-10
RS52676B (sr) 2013-06-28
EP2139479B1 (en) 2012-12-12
JP5388867B2 (ja) 2014-01-15
JP2010521502A (ja) 2010-06-24
IL200954A (en) 2014-12-31
ES2445400T3 (es) 2014-03-03
US8507526B2 (en) 2013-08-13
EP2167085B1 (en) 2013-12-25
ES2399305T3 (es) 2013-03-27

Similar Documents

Publication Publication Date Title
PL2139479T3 (pl) 4-[2-(4-Metylofenylosulfanylo)fenylo]piperydyna o połączonym hamowaniu wychwytu zwrotnego serotoniny i norepinefryny do leczenia ADHD, melancholii, depresji opornej na leczenie lub pozostałych objawów depresji
IL195310A0 (en) Crystalline forms of 4-[2-(4-methylphenylsulfanyl)- phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
EP2220074A4 (en) 3,5-SUBSTITUTED INDOL COMPOUNDS WITH NOS AND NOREPINEPHRINE RECOVERY-HEMDERING EFFECT
PL2142193T3 (pl) 1-[2-(2,4-demetylofenylosulfanylo)fenylo]piperazyna jako związek z połączonym wychwytem zwrotnym serotoniny, aktywnością względem 5HT3 i 5-HT1A do leczenia bólu lub rezydualnych objawów depresji związanych ze snem i procesami poznawczymi
NO343929B3 (no) 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte
BRPI1009893A2 (pt) limpador de superfície dura ou tratamento de superfície dura, e, método para reduzir o tempo de secagem, preferencialmente em superfícies verticais, de uma composição de limpeza líquida.
BRPI0812245A2 (pt) Método para provisão de um relaxante muscular termoestável com base no componente neurotóxico da toxina botulínica na forma sólida
BRPI0911681A2 (pt) composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula
ZA200800408B (en) Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
IL183325A0 (en) 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
DK2135861T4 (da) Fremgangsmåde til syntese af 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-on og dets anvendelse ved syntese af ivabradin såvel som dets additionssalte med en farmaceutisk acceptabel syre
JP2008013542A5 (pl)
IL201923A0 (en) Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2009014770A3 (en) Combinations of dopamine d2 receptor blockade with norepinephrine reuptake inhibition and with norepinephrine alpha 2 receptor blockade
EP2168584A4 (en) PHARMACEUTICAL COMPOSITION COMBINING TRIAZOLOBENZODIAZEPINE AND SELECTIVE SEROTONIN RECAPTURE SELECTIVE INHIBITOR
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
ZA200802774B (en) Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
TNSN08461A1 (en) Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain.
PL1897867T3 (pl) Związki stosowane do przerywania wychwytu zwrotnego 5-hydroksytryptaminy i norepinefryny lub leczenia chorób, takich jak depresja
SI1710240T1 (sl) Derivati piperazina in njihova uporaba kot zaviralci ponovnega vnosa serotonina ali kot antagonistinevrokinina
UA95801C2 (ru) Кристаллические формы 4-[2-(4-метилфенилсульфанил)-фенил]пиперидина с комбинированным ингибированием обратного захвата серотонина и норэпинефрина для лечения невропатической боли
TN2009000008A1 (en) Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
IL198999A0 (en) Compounds with a combination of cannabinobi-cb1 antagonism and serotonin reuptake inhibition
HK1115371A (en) Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
JP2007314518A5 (pl)